| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 114.029 | 16.033 | 18.651 | 20.458 | 22.707 | 24.602 | 23.032 | 24.000 | 23.976 | 13.154 |
| Total Income - EUR | 223.761 | 16.035 | 18.651 | 37.176 | 22.707 | 24.602 | 23.032 | 24.000 | 23.976 | 13.154 |
| Total Expenses - EUR | 143.065 | 14.479 | 12.637 | 50.243 | 11.153 | 6.021 | 8.998 | 9.536 | 10.034 | 8.528 |
| Gross Profit/Loss - EUR | 80.696 | 1.556 | 6.014 | -13.066 | 11.554 | 18.581 | 14.035 | 14.464 | 13.942 | 4.626 |
| Net Profit/Loss - EUR | 67.841 | 1.245 | 5.455 | -14.182 | 10.873 | 17.843 | 13.344 | 13.744 | 12.001 | 3.945 |
| Employees | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Simplex Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 93.307 | 90.049 | 86.728 | 38.252 | 35.790 | 33.580 | 31.129 | 29.515 | 27.720 | 25.868 |
| Current Assets | 30.938 | 29.332 | 27.527 | 26.761 | 18.732 | 25.202 | 24.791 | 22.097 | 22.492 | 19.347 |
| Inventories | 0 | 0 | 0 | 356 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 18.046 | 17.862 | 17.562 | 17.240 | 16.906 | 16.586 | 16.218 | 14.139 | 14.096 | 15.791 |
| Cash | 0 | 11.470 | 9.965 | 9.165 | 1.826 | 8.616 | 8.574 | 7.958 | 8.396 | 3.556 |
| Shareholders Funds | 120.783 | 53.647 | 58.194 | 39.837 | 49.938 | 56.498 | 53.626 | 51.047 | 49.217 | 44.147 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 3.462 | 65.734 | 56.061 | 25.176 | 4.583 | 2.284 | 2.295 | 565 | 994 | 1.068 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Simplex Pharm Srl